Machteld Wymenga

Rapid and Sustained Relief from the Symptoms of Carcinoid Syndrome: Results from an Open 6-Month Study of the 28-Day Prolonged-Release Formulation of Lanreotide

Philippe Ruszniewski, Sofia Ish‐Shalom, Machteld Wymenga et al. · Neuroendocrinology · 2004 · 157 citations

Medicine, Pharmacology, Pharmacotherapy +14

Phenotypic and clinical implications of variants in the dihydropyrimidine dehydrogenase gene

André B. P. Kuilenburg, Judith Meijer, Michael W.T. Tanck et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2016 · 55 citations

Life Sciences, Genetics, Molecular Genetics +14

Optimising pharmacotherapy in older cancer patients with polypharmacy

Elze Vrijkorte, Jennifer De Vries, Ron Schaafsma et al. · European Journal of Cancer Care · 2019 · 22 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Slow accrual of elderly patients with metastatic breast cancer in the Dutch multicentre OMEGA study

Marije E. Hamaker, Caroline Seynaeve, J.W.R. Nortier et al. · The Breast · 2013 · 16 citations

Medicine, Geriatric Medicine, Oncology +14